on AGP & DTx Summit
AGP & DTx Summit Highlights Digital Therapeutics Innovations
The recent AGP & DTx Summit in Shenzhen emphasized a shift in diabetes care from monitoring to effective change, showcasing a 0.54% HbA1c reduction through digital therapeutics. The event congregated international experts and stakeholders, exploring how continuous glucose monitoring (CGM) can surpass mere data collection.
Renowned figures like Prof. Andrej Janež highlighted significant global research investments in CGM and CKM, enhancing treatment accuracy even for special populations. Prof. Sofianos Andrikopoulos pointed out that digital therapeutics offer structure in diabetes intervention, combining software tools with lifestyle and medication guidance.
Further insights by Prof. Wei Qiang revealed opportunities for personalized diabetes care through integrating AGP data, whereas Prof. Shannon Lin advocated for AI-enhanced CGM for precise management. The discussions underscored the potential for patient-centered care, transitioning from monitoring to actionable health outcomes.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AGP & DTx Summit news